Advertisement
Advertisement
VRTX
Vertex Pharmaceuticals Inc
483.65
USDSponsored
+15.27
+3.26%
Jan 07, 13:47 UTC -5
Open
VRTX Earnings Reports
Positive Surprise Ratio
VRTX beat 30 of 39 last estimates.
77%
Next Report
Date of Next Report
Feb 04, 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.24B
/$5.20
Implied change from Q3 25 (Revenue/ EPS)
+5.43%
/+8.33%
Implied change from Q4 24 (Revenue/ EPS)
+11.39%
/+30.65%
Vertex Pharmaceuticals Inc earnings per share and revenue
On Nov 03, 2025, VRTX reported earnings of 4.80 USD per share (EPS) for Q3 25, beating the estimate of 4.65 USD, resulting in a 3.12% surprise. Revenue reached 3.08 billion, compared to an expected 3.11 billion, with a -1.22% difference. The market reacted with a -1.02% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 31 analysts forecast an EPS of 5.20 USD, with revenue projected to reach 3.24 billion USD, implying an increase of 8.33% EPS, and increase of 5.43% in Revenue from the last quarter.
FAQ
What were Vertex Pharmaceuticals Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Vertex Pharmaceuticals Inc reported EPS of $4.80, beating estimates by 3.12%, and revenue of $3.08B, -1.22% below expectations.
How did the market react to Vertex Pharmaceuticals Inc's Q3 2025 earnings?
The stock price moved down -1.02%, changed from $426.00 before the earnings release to $421.67 the day after.
When is Vertex Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for Feb 04, 2026.
What are the forecasts for Vertex Pharmaceuticals Inc's next earnings report?
Based on 31
analysts, Vertex Pharmaceuticals Inc is expected to report EPS of $5.20 and revenue of $3.24B for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement